Uppelschoten G.M., Wanders S.L., Âe+Jong J.M.
Single dose radiotherapy (6Gy):
palliation in painful bone metastases // Radiother. Oncol. — 1995. — V. 36(3). —
P.182 202.
Uy H.L., Mundy G.R., Boyce B.F.
è ñîàâò. Tumor necrosis factor enhances parathy
roid hormone related protein induced hypercalcemia and bone resorption without
inhibiting bone formation in vivo // Cancer Res. – 1997. — V. 57. — P. 3194 3199.
Vaananen H.
// Ann. Med. — 1993. — V. 25. — P. 353 359.
Valavaara R., Pyrhonen S., Heikkinen M.
è ñîàâò. A new antioestrogenic com
pound, for treatment of advanced breast cancer. Phase II study // Eur. J. Cancer Clin.
Oncol. — 1988. — V. 24. — P. 785 790.
van Aswegen A., Roodt A., Marais J., Botha J.M., Naude H., Lotter M.G., Goedhals
L., Doman M.J., Otto A.C
. Radiation dose estimates of 186Re hydroxyethylidene diphos
phonate for palliation of metastatic osseous lesions: an animal model study // Nucl. Med.
Commun. — 1997. — V. 18(6). — P. 582 588.
van Dalen A., Barak V., Cremaschi A., Gion M., Molina R., Namer M., Stieber P.,
Sturgeon C., Einarsson R.
The prognostic significance of increasing marker levels in
metastatic breast cancer patients with clinically complete remission, partial remission or
stable disease // Int. J. Biol. Markers. — 1998. — V. 13(1). — P. 10 15.
Vandemark R.M., Sphall Å.J., Affronti M.L.
Bone metastases from breast cancer:
value of CT bone windows // J. Comput. Assist. Tomor. — 1992. — V. 16 (4). — P. 608
614.
van der Pluijm, Vloedgraven H.,van Beek E.,
è ñîàâò. Bisphosphonates inhibit the
adhesion of breast cancer cells to bone matrices in vitro // J. Clin. Invest. — 1996. —V. 98. —
P. 698 705.
van der Pluijm, Vloedgraven H., Papapoulos S., Lowick C., Grzesik W., Kerr J., Robey
P.G.
Attachment characteristics and involvement of integrins in adhesion of breast cancer
cell lines to extracellular bone matrix components // Lab Invest. — 1997. — V. 77(6). —
P. 665 675.
Vanel D., Bittoun J., Tardivon A.
MRI of bone metastases // Eur. Radiol. — 1998. —
V. 8(8). — P. 1345 1351.
van Geffen E., Wobbes T., Veth R.P., Gelderman W.A.
Operative management of
impending pathological fractures: a critical analysis of therapy // J. Surg. Oncol. — 1997. —
V. 64(3). — P. 190 194.
Van+Houtte P., Beauvois S., Philippson C.
What is the role of radiotherapy in treat
ment of breast cancer in 1995? // Rev. Med. Brux. — 1995. — V. 16(4). — P. 237 241.
van Holten+Verzantvoort A.T., Kroon H.M., Bijvoet O.L., Cleton F.J., Beex L.V.,
Blijham G., Hermans J., Neijt J.P., Papapoulos S.E., Sleeboom H.P.
è ñîàâò. Palliative
pamidronate treatment in patients with bone metastases from breast cancer // J. Clin.
Oncol. — 1993. — V. 11(3). — P. 491 498.
van Holten+Verzantvoort A.T., Papapoulos S.E.
Oral pamidronate in the prevention
and treatment of skeletal metastases in patients with breast cancer // Medicina (B Aires). —
1997. — V. 57(Suppl. 1). — P. 109 113.
Vargas S.J., Gillespie M.T., Powell G.J.,
è ñîàâò. Localization of parathyroid hor
mone related protein mRNA expression in breast cancer and metastatic lesions by in situ
hybridation // J. Bone Miner. Res. — 1992. — V. 7. — P. 971 979.
Vargha Z.O., Glicksman A.S., Boland J.
Single dose radiation therapy in the pallia
tion of metastatic disease // Radiology. — 1969. — V. 93. — P. 1181 1184.
252
Êîñòíûå ìåòàñòàçû ðàêà ìîëî÷íîé æåëåçû
